Advertisement

August 3, 2015

Boston Scientific Announces Strategic Alliance With Preventice Solutions

August 3, 2015—Boston Scientific Corporation announced that it has become a significant shareholder and will become the exclusive worldwide sales and marketing representative for Preventice Solutions for cardiology-related diagnostic and monitoring offerings. The transaction provides access for Boston Scientific to the Preventice wireless monitoring portfolio linked to an integrated remote monitoring platform. Preventice Solutions is a privately held company based in Rochester, Minnesota. 

According to Boston Scientific, Preventice Solutions develops mobile health solutions and services and offers a portfolio of wearable cardiac monitors, including Holter monitors, cardiac-event monitors, and mobile cardiac telemetry. These technologies are complemented by monitoring services including data transmission, surveillance, reporting, interpretation, and integration into a healthcare provider's workflow. Preventice Solutions’ portfolio includes the PatientCare Platform and the BodyGuardian family of products for remote cardiac monitoring.

Advertisement


August 5, 2015

FDA Issues Safety Communication on Implantable Left Ventricular Assist Devices

August 3, 2015

FDA Issues Safety Communication on Name Confusions for Brilinta and Brintellix